Why the study?
Selecting the optimal BP measurement device is challenging given the overwhelming number of largely untested devices on the market, especially in low-resource settings.
Key points are not available for this paper at this time.
Design
Review
Answers are grounded in this paper and cite their sources.
Prioritize validated devices in low-resource hypertension programs; extends selection criteria but leaves open real-world outcome trials.
High blood pressure (BP) is the single leading preventable cardiovascular disease (CVD) risk factor across the world. In order to decrease the global burden of CVD, broad hypertension screening programs that facilitate early hypertension diagnosis and treatment are essential. Accurate BP devices are a key element of hypertension control programs. With the overwhelming number of devices available now on the market, most of which have not been tested for accuracy, it can be challenging to select the optimal BP measurement device for clinical settings. This review details essential factors to consider when selecting a good-quality BP device, particularly for use in low-resource settings. Barriers to the procurement and use of good-quality devices are reviewed and practical solutions proposed.
No takes yet. Share an insight, caveat, or question.
Brady et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: